Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Brentuximab Vedotin × 1 year × Clear all

Phase

Status

Active not recruiting 14 Completed 12 Recruiting 11 Terminated 1 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 20 Biopsy 15 Cyclophosphamide 13 Vincristine 7 Nivolumab 6 Doxorubicin 6 Bevacizumab 6 pembrolizumab 5 Prednisone 5 Etoposide 5 Cisplatin 5 venetoclax 4 fludarabine 4 durvalumab 4 atezolizumab 4 Rituximab 4 Radiosurgery 4 Radiation 4 Lenalidomide 4 Ipilimumab 4 Carboplatin 4 prednylidene 3 fludarabine phosphate 3 deltacortene 3 X-Rays 3 Surveys and Questionnaires 3 Educational Status 3 Dexamethasone 3 Cytarabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03187210 2025-03-30

BAL

Insel Gruppe AG, University Hospital Bern

Phase 1/2 Suspended

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡